Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population

被引:61
作者
Choi, Kyung Mook
Kim, Seon Mee
Kim, Yeong-Eun
Choi, Dong Seop
Baik, Sei Hyun
Lee, Juneyoung [1 ]
机构
[1] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea
[2] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136701, South Korea
[3] Korea Univ, Coll Med, Dept Family Med, Seoul 136701, South Korea
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2007年 / 56卷 / 04期
关键词
D O I
10.1016/j.metabol.2006.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To compare the prevalence of the metabolic syndrome using the National Cholesterol Education Program (NCEP) and the International Diabetes Federation (IDF) definitions and to contrast the association between the prevalence of cardiovascular disease and the metabolic syndrome using both definitions in the Korean population, we used data from the 2001 Korean Nation Health and Nutrition Survey, which is a nationally representative survey of the noninstitutionalized civilian population. The age-adjusted prevalence of the metabolic syndrome was 18.8% +/- 0.5% (men, 17.8% +/- 0.8%; women, 20.5% +/- 0.7%) using the NCEP definition and 19.5% +/- 0.5% (men 15.0% +/- 0.8%, women 23.9% +/- 0.7%) using the IDF definition among participants 20 years or older. The agreement rate, which is the percentage of participants who were classified as either having or not having the metabolic syndrome by both definitions of the metabolic syndrome, was 84.6% 0.5% (kappa = 0.54). The prevalence of the metabolic syndrome using the NCEP definition was higher in participants with lower body mass index, whereas the prevalence using the IDF definition was higher in subjects with higher body mass index. The odds ratio (OR) for coronary artery disease was 3.5 (95% confidence interval [CI], 2.0-6.1) for participants with the metabolic syndrome defined by the NCEP definition, whereas it was 2.8 (95% CI, 1.6-5.0) for those with the metabolic syndrome defined by the IDF definition. Similarly, the OR for stroke was higher using the NCEP definition (OR, 3.0; 95% CI, 1.7-5.2) compared with that of the IDF definition (OR, 2.3; 95% CI, 1.3-4.0). However, the CIs by both definitions overlapped considerably. In conclusion, the prevalence of the metabolic syndrome using the IDF definition was higher than that using the NCEP definition, whereas the NCEP definition was more closely associated with cardiovascular disease in the Korean population. (c) 2007 Published by Elsevier Inc.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 26 条
[1]   Population comparison of two clinical approaches to the metabolic syndrome - Implications of the new International Diabetes Federation consensus definition [J].
Adams, RJ ;
Appleton, S ;
Wilson, DH ;
Taylor, AW ;
Dal Grande, E ;
Chittleborough, C ;
Gill, T ;
Ruffin, R .
DIABETES CARE, 2005, 28 (11) :2777-2779
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
[Anonymous], AS PAC PERSP RED OB
[5]  
Balkau B, 1999, DIABETIC MED, V16, P442
[6]   How good is that agreement? [J].
Byrt, T .
EPIDEMIOLOGY, 1996, 7 (05) :561-561
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   The rising prevalence of diabetes and impaired glucose tolerance - The Australian diabetes, obesity and lifestyle study [J].
Dunstan, DW ;
Zimmet, PZ ;
Welborn, TA ;
de Courten, MP ;
Cameron, AJ ;
Sicree, RA ;
Dwyer, T ;
Colagiuri, S ;
Jolley, D ;
Knuiman, M ;
Atkins, R ;
Shaw, JE .
DIABETES CARE, 2002, 25 (05) :829-834
[9]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[10]  
Einhorn Daniel, 2003, Endocr Pract, V9, P237